Literature DB >> 10844380

Relationship between endogenous sex hormone levels, lipoproteins and coronary atherosclerosis in men undergoing coronary angiography.

G Kabakci1, A Yildirir, I Can, I Unsal, B Erbas.   

Abstract

This study was carried out in order to investigate the relationship between endogenous sex steroid hormones and coronary artery disease (CAD). Three hundred and thirty-seven men undergoing coronary angiography were enrolled in the study. Total testosterone, estradiol, free testosterone levels in men with CAD (n = 213) were compared to those of men without CAD (n = 124). No significant differences were found in the serum concentrations of estradiol, total and free testosterone and serum lipid profile between the two groups. Total and free testosterone were negatively (p < 0.05 to p < 0.001) and estradiol was positively (p < 0.05) correlated with age in both groups. Total cholesterol and low-density-lipoprotein levels were positively correlated with the level of free testosterone (r = 0.221, p < 0.01; r = 0.173, p < 0.05, respectively), and high-density-lipoprotein levels were negatively correlated with total testosterone in patients with CAD (r = -0.166, p < 0.05). The results of this study do not support the role of sex steroid hormones in CAD. However, the relationship between sex steroids and serum lipids needs further clarification.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10844380     DOI: 10.1159/000006977

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  10 in total

Review 1.  Androgens and male aging: Current evidence of safety and efficacy.

Authors:  Louis J Gooren
Journal:  Asian J Androl       Date:  2010-02-15       Impact factor: 3.285

Review 2.  Relationship between testosterone deficiency and cardiovascular risk and mortality in adult men.

Authors:  C Cattabiani; S Basaria; G P Ceda; M Luci; A Vignali; F Lauretani; G Valenti; R Volpi; M Maggio
Journal:  J Endocrinol Invest       Date:  2011-11-08       Impact factor: 4.256

3.  Higher testosterone levels are associated with increased high-density lipoprotein cholesterol in men with cardiovascular disease: results from the Massachusetts Male Aging Study.

Authors:  Stephanie T Page; Beth A Mohr; Carol L Link; Amy B O'Donnell; William J Bremner; John B McKinlay
Journal:  Asian J Androl       Date:  2007-12-20       Impact factor: 3.285

Review 4.  Reactive oxygen species: players in the cardiovascular effects of testosterone.

Authors:  Rita C Tostes; Fernando S Carneiro; Maria Helena C Carvalho; Jane F Reckelhoff
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-11-04       Impact factor: 3.619

5.  Hypogonadism in the aging male diagnosis, potential benefits, and risks of testosterone replacement therapy.

Authors:  Prasanth N Surampudi; Christina Wang; Ronald Swerdloff
Journal:  Int J Endocrinol       Date:  2012-03-14       Impact factor: 3.257

6.  Testosterone as a marker of coronary artery disease severity in middle aged males.

Authors:  Kunal Gururani; John Jose; Paul V George
Journal:  Indian Heart J       Date:  2016-08-08

7.  The benefits and risks of testosterone replacement therapy: a review.

Authors:  Nazem Bassil; Saad Alkaade; John E Morley
Journal:  Ther Clin Risk Manag       Date:  2009-06-22       Impact factor: 2.423

Review 8.  Anabolic steroids, acute myocardial infarction and polycythemia: a case report and review of the literature.

Authors:  Kathleen Stergiopoulos; Joseph J Brennan; Robin Mathews; John F Setaro; Smadar Kort
Journal:  Vasc Health Risk Manag       Date:  2008

Review 9.  Testosterone and the cardiovascular system: a comprehensive review of the clinical literature.

Authors:  Peyman Mesbah Oskui; William J French; Michael J Herring; Guy S Mayeda; Steven Burstein; Robert A Kloner
Journal:  J Am Heart Assoc       Date:  2013-11-15       Impact factor: 5.501

10.  The relationship between level of androgenic hormones and coronary artery disease in men.

Authors:  Gholamreza Davoodi; Alireza Amirezadegan; Mohammad Ali Borumand; Maria Raissi Dehkori; Ali Kazemisaeid; Ahmad Yaminisharif
Journal:  Cardiovasc J Afr       Date:  2007 Nov-Dec       Impact factor: 1.167

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.